Hodgkin’s lymphoma associated with hemophagocytic lymphohistiocytosis: A challenging combination | Zendy

Arif Alam | Zendy; Fatima AlKendi | Zendy; Jihad Kanbar | Zendy; Mohammed Jaloudi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Hodgkin’s lymphoma associated with hemophagocytic lymphohistiocytosis: A challenging combination

Author(s) -

Arif Alam,

Fatima AlKendi,

Jihad Kanbar,

Mohammed Jaloudi

Publication year - 2016

Publication title -

advances in modern oncology research

Language(s) - English

Resource type - Journals

eISSN - 2424-7855

pISSN - 2424-7847

DOI - 10.18282/amor.v2.i3.65

Subject(s) - procarbazine , hemophagocytic lymphohistiocytosis , medicine , bleomycin , etoposide , vincristine , hodgkin lymphoma , prednisone , lymphoma , cyclophosphamide , dacarbazine , oncology , cancer research , chemotherapy , disease

Hemophagocytic lymphohistiocytosis (HLH) is a hyper inflammatory disorder. In this case report, we described our experience with an associated diagnosis of Hodgkin’s lymphoma (HL) and a therapeutic course using “bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone” (BEACOPP) chemotherapy to treat both HLH and HL.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research